# Naomi V. Dahl

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/naomi-v-dahl/

## Facts

| Field | Value |
| --- | --- |
| Citations | 2,130 |
| Field | Iron Metabolism and Disorders |
| h-index | 21 |
| i10-index | 32 |
| Last Known Institution | AMAG Pharmaceuticals (United States) |
| OpenAlex ID | https://openalex.org/A5027452855 |
| ORCID iD | 0000-0003-2904-3664 |
| Works | 78 |

## Researcher papers

- [Ferric Gluconate Is Highly Efficacious in Anemic Hemodialysis Patients with High Serum Ferritin and Low Transferrin Saturation](https://scholariq.org/papers/ferric-gluconate-is-highly-efficacious-in-anemic-hemodialysis-patients-with-high/)
- [Intravenous Ferric Gluconate Significantly Improves Response to Epoetin Alfa Versus Oral Iron or No Iron in Anemic Patients with Cancer Receiving Chemotherapy](https://scholariq.org/papers/intravenous-ferric-gluconate-significantly-improves-response-to-epoetin-alfa/)
- [Ferric Gluconate Reduces Epoetin Requirements in Hemodialysis Patients with Elevated Ferritin](https://scholariq.org/papers/ferric-gluconate-reduces-epoetin-requirements-in-hemodialysis-patients-with/)
- [Safety and efficacy of rapidly administered (one hour) one gram of low molecular weight iron dextran (INFeD) for the treatment of iron deficient anemia](https://scholariq.org/papers/safety-and-efficacy-of-rapidly-administered-one-hour-one-gram-of-low-molecular/)
- [Sodium ferric gluconate complex in hemodialysis patients. II. Adverse reactions in iron dextran-sensitive and dextran-tolerant patients](https://scholariq.org/papers/sodium-ferric-gluconate-complex-in-hemodialysis-patients-ii-adverse-reactions-in/)
- [Oxybutynin transdermal system improves the quality of life in adults with overactive bladder: a multicentre, community‐based, randomized study](https://scholariq.org/papers/oxybutynin-transdermal-system-improves-the-quality-of-life-in-adults-with/)
- [The impact of the overactive bladder syndrome on sexual function: A preliminary report from the Multicenter Assessment of Transdermal Therapy in Overactive Bladder with Oxybutynin trial](https://scholariq.org/papers/the-impact-of-the-overactive-bladder-syndrome-on-sexual-function-a-preliminary/)
- [<p>Hypophosphatemia Associated with Intravenous Iron Therapies for Iron Deficiency Anemia: A Systematic Literature Review</p>](https://scholariq.org/papers/and-lt-p-and-gt-hypophosphatemia-associated-with-intravenous-iron-therapies-for/)
- [Thrombocytosis and venous thromboembolism in cancer patients with chemotherapy induced anemia may be related to ESA induced iron restricted erythropoiesis and reversed by administration of IV iron](https://scholariq.org/papers/thrombocytosis-and-venous-thromboembolism-in-cancer-patients-with-chemotherapy/)
- [Iron therapy in the pediatric hemodialysis population](https://scholariq.org/papers/iron-therapy-in-the-pediatric-hemodialysis-population/)

## Researcher topics

- [Iron Metabolism and Disorders](https://scholariq.org/topics/iron-metabolism-and-disorders/)
- [Erythropoietin and Anemia Treatment](https://scholariq.org/topics/erythropoietin-and-anemia-treatment/)
- [Hemoglobinopathies and Related Disorders](https://scholariq.org/topics/hemoglobinopathies-and-related-disorders/)
- [Urinary Bladder and Prostate Research](https://scholariq.org/topics/urinary-bladder-and-prostate-research/)
- [Pelvic floor disorders treatments](https://scholariq.org/topics/pelvic-floor-disorders-treatments/)

## Researcher university

- [AMAG Pharmaceuticals (United States)](https://scholariq.org/institutions/amag-pharmaceuticals-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.